Chrome · 120 tablets
Chromium is a trace element that determines numerous functions in the human body. In addition to blood sugar levels and various metabolic processes, chromium also influences a whole range of other processes. As always, GN supplies the active ingredient in the highest quality so that nothing stands in the way of an optimum effect.
- Influences blood sugar levels and insulin metabolism
- Influences numerous metabolic processes
- Can counteract a chromium deficiency
- Highly dosed
- Easy to dose
- Highest quality - made in Germany
Nährwerte und Inhaltsstoffe
Composition | per 1/2 tablet | %(NRV) |
---|---|---|
Chromium | 100 µg | 250% |
Zutaten: Füllstoff und Trennmittel: Microcrystalline Cellulose, Chrompicolinat.
*Prozent der empfohlenen täglichen Verzehrmenge laut Verordnung (EU) Nr. 1196/2011
**Keine Nährstoffbezugswerte (NRV) vorhanden.
Verzehrempfehlung
Hinweise
Hersteller / Distributor
GN Laboratories Europe, London / United Kingdom
Nero Labs BV, Postbus 278, 5900AG Venlo, The Netherlands
Quellen
Quellenverzeichnis
(1) Zhao, F., Pan, D., Wang, N., Xia, H., Zhang, H., Wang, S., & Sun, G. (2022). Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis. Biological trace element research, 200(2), 516–525. https://doi.org/10.1007/s12011-021-02693-3
(2) Dubey, P., Thakur, V., & Chattopadhyay, M. (2020). Role of Minerals and Trace Elements in Diabetes and Insulin Resistance. Nutrients, 12(6), 1864. https://doi.org/10.3390/nu12061864
(3) Vincent, J. B., & Lukaski, H. C. (2018). Chromium. Advances in nutrition (Bethesda, Md.), 9(4), 505–506. https://doi.org/10.1093/advances/nmx021
(4) Wang, Y. Q., Dong, Y., & Yao, M. H. (2009). Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of amp-activated protein kinase. Clinical and experimental pharmacology & physiology, 36(8), 843–849. https://doi.org/10.1111/j.1440-1681.2009.05164.x
(5) Pavlic, M., & Lewis, G. F. (2011). Lipid metabolism. Current opinion in lipidology, 22(5), 433–436. https://doi.org/10.1097/MOL.0b013e32834b0d6c
(6) Piotrowska, A., Pilch, W., Czerwińska-Ledwig, O., Zuziak, R., Siwek, A., Wolak, M., & Nowak, G. (2019). The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome. Biological trace element research, 192(2), 91–97. https://doi.org/10.1007/s12011-019-1654-5
(7) Nenezic, N., Kostic, S., Strac, D. S., Grunauer, M., Nenezic, D., Radosavljevic, M., Jancic, J., & Samardzic, J. (2023). Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application. Mini reviews in medicinal chemistry, 23(8), 941–952. https://doi.org/10.2174/1389557522666220919125817
(8) Shrivastava, R., Upreti, R. K., Seth, P. K., & Chaturvedi, U. C. (2002). Effects of chromium on the immune system. FEMS immunology and medical microbiology, 34(1), 1–7. https://doi.org/10.1111/j.1574-695X.2002.tb00596.x
(9) Suksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014). Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. Journal of clinical pharmacy and therapeutics, 39(3), 292–306. https://doi.org/10.1111/jcpt.12147
(10)Anton, S. D., Morrison, C. D., Cefalu, W. T., Martin, C. K., Coulon, S., Geiselman, P., Han, H., White, C. L., & Williamson, D. A. (2008). Effects of chromium picolinate on food intake and satiety. Diabetes technology & therapeutics, 10(5), 405–412. https://doi.org/10.1089/dia.2007.0292
Inhalt: 120 tablets Artikelnr.: 6132